ITEMS IN AFP WITH KEYWORD:
The risk of fetal aneuploidy, the presence of one or more extra chromosomes or the absence of one or more chromosomes, rises with increasing maternal age. Because fetal aneuploidy can affect any pregnancy, all pregnant women should be offered screening. Screening can be done in the first or second trimester, or a combination of both. Because no screening test is diagnostic, patients with positive screening results should be referred for invasive diagnostic testing.
Jan 15, 2020 Issue
Screening for Hepatitis B Virus Infection in Pregnant Women: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit.
A 33-year-old U.S.-born pregnant clinician comes to your office for a first prenatal visit. Her most recent menstrual period was six weeks ago, and she has been taking prenatal vitamins for the past eight weeks. She was pregnant once more than two years ago, and at the time she screened negative for the hepatitis B virus (HBV).
Jan 1, 2020 Issue
Antepartum Omega-3 Fatty Acid Intake and Length of Gestation [Cochrane for Clinicians]
Omega-3 fatty acids, whether taken as supplements or consumed as part of the diet, reduce the risk of preterm birth (number needed to treat = 68) and early preterm birth (number needed to treat = 55).
The American College of Obstetricians and Gynecologists (ACOG) has released an updated practice bulletin to outline diagnosis, effects on pregnancy outcomes, and approaches for management based on new evidence.
Nov 15, 2019 Issue
Gestational Hypertension and Preeclampsia: A Practice Bulletin from ACOG [Practice Guidelines]
Globally, hypertensive disorders of pregnancy are one of the main causes of maternal death. The American College of Obstetricians and Gynecologists has released a practice bulletin to outline diagnosis and treatment recommendations for these conditions.
Oct 1, 2019 Issue
Antihypertensive Drug Therapy for Mild to Moderate Hypertension During Pregnancy [Cochrane for Clinicians]
Compared with placebo, antihypertensive drug therapy for mild to moderate hypertension (defined by the authors as a blood pressure of 140 to 169 mm Hg systolic or 90 to 109 mm Hg diastolic) caused by chronic hypertension, gestational hypertension, or preeclampsia during pregnancy does not affect any pregnancy outcomes.
Jul 15, 2019 Issue
Interpregnancy Care: Guidelines from ACOG and SMFM [Practice Guidelines]
The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine have published guidelines focusing on interpregnancy care to improve outcomes of future pregnancies and the overall health of women, regardless of their future pregnancy plans.
Apr 15, 2019 Issue
Screening for Syphilis In Pregnant Women: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends early screening for syphilis infection in all pregnant women.
Mar 1, 2019 Issue
Metformin for Improving Maternal and Infant Outcomes in Pregnant Women Who Are Obese [Medicine by the Numbers]
This meta-analysis showed no clear benefit for metformin in reducing the risk of large for gestational age infants. Additionally, there was no difference in important secondary outcomes such as gestational diabetes, hypertensive disease in pregnancy, shoulder dystocia, advanced perineal lacerations,...